Technical Assistance Webinar for RFA-NS-22-002 HEAL Initiative: Advancing Health Equity in Pain Management (R61/R33 Clinical Trial Required)
Wed, 10/27/2021 - 1:00pm - 2:00pm
Overview
The National Institute of Neurological Disorders and Stroke (NINDS) hosted a pre-application technical assistance webinar on October 27, 2021, from 1 to 2 p.m. (Eastern Time) for all potential applicants interested in the following Funding Opportunity Announcement (NOFO): RFA-NS-22-002 – HEAL Initiative: Advancing Health Equity in Pain Management (R61/R33 Clinical Trial Required).
This NOFO aims to accelerate development, testing and implementation of evidence-based interventions—that are culturally and linguistically appropriate for NIH-designated populations that experience health disparities (HDPs) in the United States—to mitigate disparities in provision of care and treatment decisions, reduce susceptibility to chronic pain and improve patient outcomes. NIH program and review staff provided an overview of the RFA, including objectives, application instructions and review criteria and answered questions. Participation in this webinar was optional and not required for the submission of an application.
View the webinar recording
Topics Covered
- RFA background, objectives, expectations, and timeline
- Peer review of applications
- Participant questions
Key Takeaways From the Event
- The RFA-NS-22-002 application deadline for submission is December 9, 2021.
- We suggest applicants carefully review the RFA-NS-22-002 in great detail.
- We recommend applicants reach out to webinar presenters or IC-specific contacts to ask specific questions related to your application.
- We encourage prospective applicants to submit a letter of intent by November 9, 2021.
Speakers
Cheryse A. Sankar, Ph.D.
Office of Pain Policy and Planning
National Institute of Neurological Disorders and Stroke
Yolanda F. Vallejo, Ph.D.
Program Director
National Center for Advancing Translational Sciences
Joseph Rudolph, Ph.D.
Chief, Emerging Technologies and Training in the Neurosciences
Center for Scientific Review